Suven Life Sciences net down 11.5%

Suven Life Sciences net profit declined 11.5 per cent at ₹32.2 crore in the third quarter ended December 31, 2014, against ₹36 crore in the corresponding quarter of previous year. Total income, however, increased 9 per cent at ₹131 crore (₹120 crore). The reduction in profit was due to charge of additional depreciation computed as per the Companies Act 2013 effective April 1, 2014, shown as exceptional item in the profit & loss account.